The legislation details the money would be used for a media campaign, grants to pay for screenings and written materials to ...

Telomir Pharmaceuticals (NASDAQ: TELO) has announced groundbreaking preclinical findings suggesting that its licensed molecule, Telomir-1, can reverse key Type 2 diabetes parameters. As a leader in ...

Fatty, salty and sugary ultra-processed foods could be increasing people's risk of colon cancer by spurring chronic ...

Professor Dr. Othmar Moser from the University of Bayreuth is the lead author of the new international guideline on exercise ...

AFib-treating cardiac ablation, surgical robotics, nitinol and diabetes treatment tech lead among this year’s top medtech ...

They’ve been heralded as the magic drugs that treat obesity when diet and exercise have failed. But Ozempic and Wegovy – and ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

With data 'locked' in medical devices, sociologist Shane O'Donnell explains how people with Type 1 diabetes are turning to community-built, open-source innovations.

Doctors might be slow to admit it, but Ozempic and other GLP-1 drugs are making dieting and exercise obsolete.

People with type 2 diabetes have a higher risk of developing cardiovascular disease and dying prematurely due to atherosclerosis.

Metabolic dysfunction-associated steatotic liver disease (MASLD) is currently a pressing public health issue associated with ...

The overwhelming support for Donald Trump on Nov 5, 2024, for the US presidential election, came as a surprise to many. The impact of the US election outcome on public health in general, and womens' ...